Comprehensive Money Management Services LLC Sells 750 Shares of Sabra Healthcare REIT, Inc. $SBRA

Comprehensive Money Management Services LLC reduced its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,660 shares of the real estate investment trust’s stock after selling 750 shares during the period. Comprehensive Money Management Services LLC’s holdings in Sabra Healthcare REIT were worth $363,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. SVB Wealth LLC bought a new position in shares of Sabra Healthcare REIT in the first quarter worth $34,000. UMB Bank n.a. boosted its holdings in shares of Sabra Healthcare REIT by 379.6% in the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust’s stock worth $36,000 after acquiring an additional 1,621 shares during the period. Wealth Preservation Advisors LLC bought a new position in shares of Sabra Healthcare REIT in the first quarter worth $38,000. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Sabra Healthcare REIT by 61.2% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust’s stock worth $49,000 after acquiring an additional 1,065 shares during the period. Finally, Anchor Investment Management LLC bought a new position in shares of Sabra Healthcare REIT in the first quarter worth $58,000. 99.40% of the stock is owned by institutional investors.

Sabra Healthcare REIT Trading Down 0.8%

NASDAQ SBRA opened at $17.74 on Friday. The stock’s 50-day simple moving average is $18.76 and its two-hundred day simple moving average is $18.17. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.03. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $4.25 billion, a price-to-earnings ratio of 23.34, a PEG ratio of 1.20 and a beta of 0.85.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same quarter last year, the business posted $0.36 earnings per share. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 157.89%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the company. Scotiabank increased their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research report on Monday, June 23rd. BMO Capital Markets increased their price objective on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research report on Monday, August 25th. Weiss Ratings reiterated a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday. JMP Securities increased their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “market outperform” rating in a research report on Wednesday, August 6th. Finally, Wells Fargo & Company increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Sabra Healthcare REIT has an average rating of “Moderate Buy” and a consensus target price of $20.71.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.